Alnylam Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,100
Employees2,100
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,100
Employees2,100
ALNY Key Statistics
Market cap18.56B
Market cap18.56B
Price-Earnings ratio-41.37
Price-Earnings ratio-41.37
Dividend yield—
Dividend yield—
Average volume650.40K
Average volume650.40K
High today$151.00
High today$151.00
Low today$147.22
Low today$147.22
Open price$150.45
Open price$150.45
Volume442.50K
Volume442.50K
52 Week high$218.88
52 Week high$218.88
52 Week low$143.52
52 Week low$143.52
ALNY News
Yahoo Finance 6d
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited ... - Yahoo FinanceFamily Health History Road Trip highlights video Educational brochure about hereditary ATTR (hATTR) amyloidosis Hereditary ATTR (hATTR) amyloidosis family dis...
Analyst ratings
70%
of 30 ratingsBuy
70%
Hold
30%
Sell
0%